Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comment on "Development and Validation of a META-Algorithm to Identify the Indications of Use of Biological Drugs Approved for the Treatment of Immune-Mediated Inflammatory Diseases from Claims Databases: Insights from the VALORE Project". [Response to Letter].
Spini A, L'Abbate L, Ingrasciotta Y, Pellegrini G, Carollo M, Ientile V, Leoni O, Zanforlini M, Ancona D, Stella P, Cavazzana A, Scapin A, Lopes S, Belleudi V, Trifirò G. Spini A, et al. Among authors: zanforlini m. Clin Epidemiol. 2024 Jun 26;16:445-446. doi: 10.2147/CLEP.S482719. eCollection 2024. Clin Epidemiol. 2024. PMID: 38946927 Free PMC article. No abstract available.
Development and Validation of a META-Algorithm to Identify the Indications of Use of Biological Drugs Approved for the Treatment of Immune-Mediated Inflammatory Diseases from Claims Databases: Insights from the VALORE Project.
Spini A, L'Abbate L, Ingrasciotta Y, Pellegrini G, Carollo M, Ientile V, Leoni O, Zanforlini M, Ancona D, Stella P, Cavazzana A, Scapin A, Lopes S, Belleudi V, Trifirò G. Spini A, et al. Among authors: zanforlini m. Clin Epidemiol. 2024 Jun 4;16:395-407. doi: 10.2147/CLEP.S445120. eCollection 2024. Clin Epidemiol. 2024. PMID: 38854895 Free PMC article.
Switching patterns of biological drugs in patients with psoriasis and psoriatic arthritis: insight from the VALORE database network.
Spini A, Pellegrini G, Ingrasciotta Y, L'Abbate L, Bellitto C, Carollo M, Leoni O, Zanforlini M, Ancona D, Stella P, Cavazzana A, Scapin A, Lopes S, Belleudi V, Ledda S, Carta P, Rossi P, Ejlli L, Sapigni E, Puccini A, Spila Alegiani S, Massari M, Guarneri C, Gisondi P, Trifirò G. Spini A, et al. Among authors: zanforlini m. Expert Opin Biol Ther. 2024 May;24(5):399-409. doi: 10.1080/14712598.2024.2357381. Epub 2024 May 21. Expert Opin Biol Ther. 2024. PMID: 38767132
How a laboratory-based antimicrobial resistance (AMR) regional surveillance system can address large-scale and local AMR epidemiology: the MICRO-BIO experience.
Comelli A, Zanforlini M, Mazzone A, Pedroni P, De Castro U, Scarioni S, D'Amelio AC, Renisi G, Bandera A, Gori A, Schiatti S, Cereda D; MICROBIO LR Group. Comelli A, et al. Among authors: zanforlini m. Front Public Health. 2024 Feb 12;12:1341482. doi: 10.3389/fpubh.2024.1341482. eCollection 2024. Front Public Health. 2024. PMID: 38410663 Free PMC article.
Comparing clinical trial population representativeness to real-world users of 17 biologics approved for immune-mediated inflammatory diseases: An external validity analysis of 66,639 biologic users from the Italian VALORE project.
Ingrasciotta Y, Spini A, L'Abbate L, Fiore ES, Carollo M, Ientile V, Isgrò V, Cavazzana A, Biasi V, Rossi P, Ejlli L, Belleudi V, Poggi F, Sapigni E, Puccini A, Ancona D, Stella P, Pollina Addario S, Allotta A, Leoni O, Zanforlini M, Tuccori M, Gini R, Trifirò G. Ingrasciotta Y, et al. Among authors: zanforlini m. Pharmacol Res. 2024 Feb;200:107074. doi: 10.1016/j.phrs.2024.107074. Epub 2024 Jan 15. Pharmacol Res. 2024. PMID: 38232909 Free article.
Immunosuppression with Generics in Liver and Kidney Transplantation: A Real-World Evidence Study.
Finocchietti M, Marino ML, Rosa AC, Bellini A, Masiero L, Cardillo M, Massari M, Spila Alegiani S, Pierobon S, Ferroni E, Zanforlini M, Leoni O, Ledda S, Garau D, Davoli M, Addis A, Belleudi V; CESIT Study Group. Finocchietti M, et al. Among authors: zanforlini m. Drug Des Devel Ther. 2024 Jan 12;18:53-69. doi: 10.2147/DDDT.S431121. eCollection 2024. Drug Des Devel Ther. 2024. PMID: 38229916 Free PMC article.
Determinants of immunosuppressive therapy in renal transplant recipients: an Italian observational study (the CESIT project).
Rosa AC, Finocchietti M, Agabiti N, Menè P, Bracaccia ME, Bellini A, Massari M, Spila Alegiani S, Masiero L, Bedeschi G, Cardillo M, Lucenteforte E, Piccolo G, Leoni O, Ferroni E, Pierobon S, Nordio M, Ledda S, Garau D, Davoli M, Addis A, Belleudi V; CESIT study group. Rosa AC, et al. BMC Nephrol. 2023 Oct 27;24(1):320. doi: 10.1186/s12882-023-03325-9. BMC Nephrol. 2023. PMID: 37891504 Free PMC article.
Temporal and spatial variability of immunosuppressive therapies in transplant patients: An observational study in Italy.
Marino ML, Rosa AC, Finocchietti M, Bellini A, Poggi FR, Massari M, Spila Alegiani S, Masiero L, Ricci A, Bedeschi G, Puoti F, Cardillo M, Pierobon S, Nordio M, Ferroni E, Zanforlini M, Piccolo G, Leoni O, Ledda S, Carta P, Garau D, Lucenteforte E, Davoli M, Addis A, Belleudi V. Marino ML, et al. Among authors: zanforlini m. Front Transplant. 2023 Jan 16;1:1060621. doi: 10.3389/frtra.2022.1060621. eCollection 2022. Front Transplant. 2023. PMID: 38994384 Free PMC article.
An Italian multicentre distributed data research network to study the use, effectiveness, and safety of immunosuppressive drugs in transplant patients: Framework and perspectives of the CESIT project.
Belleudi V, Rosa AC, Finocchietti M, Poggi FR, Marino ML, Massari M, Spila Alegiani S, Masiero L, Ricci A, Bedeschi G, Puoti F, Cardillo M, Pierobon S, Nordio M, Ferroni E, Zanforlini M, Piccolo G, Leone O, Ledda S, Carta P, Garau D, Lucenteforte E, Davoli M, Addis A; CESIT Study Group. Belleudi V, et al. Among authors: zanforlini m. Front Pharmacol. 2022 Sep 15;13:959267. doi: 10.3389/fphar.2022.959267. eCollection 2022. Front Pharmacol. 2022. PMID: 36188626 Free PMC article.
Large-Scale Postmarketing Surveillance of Biological Drugs for Immune-Mediated Inflammatory Diseases Through an Italian Distributed Multi-Database Healthcare Network: The VALORE Project.
Trifirò G, Isgrò V, Ingrasciotta Y, Ientile V, L'Abbate L, Foti SS, Belleudi V, Poggi F, Fontana A, Moretti U, Lora R, Sabaini A, Senesi I, Sorrentino C, Puzo MR, Padula A, Fusco M, Giordana R, Solfrini V, Puccini A, Rossi P, Del Zotto S, Leoni O, Zanforlini M, Ancona D, Bavaro V, Garau D, Ledda S, Scondotto S, Allotta A, Tuccori M, Gini R, Bucaneve G, Franchini D, Cavazzana A, Biasi V, Spila Alegiani S, Massari M; VALORE Project Collaborators. Trifirò G, et al. Among authors: zanforlini m. BioDrugs. 2021 Nov;35(6):749-764. doi: 10.1007/s40259-021-00498-3. Epub 2021 Oct 12. BioDrugs. 2021. PMID: 34637126 Free PMC article.